fbpx

Day

februar 4, 2019
CAMBRIDGE, Mass., Feb. 04, 2019 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant (MDR) bacterial infections, today announced the acceptance by the U.S. Food and Drug Administration (FDA) of its Investigational New Drug (IND) application for SPR994,...

Nyheder

Hun fik så mange gode ideer når hun cyklede hjem fra arbejde
11. april 2019
Hjernens ’søhest’ skal sikre bedre behandling af psykiske lidelser
9. april 2019
Danske forskere vil spore hjerne-blodpropper 10.000 år tilbage
4. april 2019

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge